Individualizing Heart Failure Treatment

Title:

Individualizing Heart Failure Treatment

Topic: Cardiology
Relevant Terms: Heart failure; racial disparities; heart rate; biomarkers
Primary Audience: Primary Care MD/DO and NPs/PAs and other clinicians managing patients with Heart Failure
Launch Date: 19-Oct-16
Credits: AMA PRA Category 1 Credit
1 AANP contact hour of continuing education
Expiration Date: 18-Oct-17
Curriculum Name: Recognizing and Managing Heart Failure in Primary Care

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment
  2. Recognize the importance of heart rate in cardiovascular risk of heart failure
  3. Utilize the most recent clinical evidence to inform decisions for the management of heart failure
  4. Identify approaches to facilitate early recognition and optimization of heart failure management

    Faculty

    Barbara A. Hutchinson, MD, PhD, FACC
    Managing Partner
    Chespeake Cardiac Care
    Annapolis, MD
    Anekwe Onwuanyi, MD, FACC, FAHA, FACP, FHFSA
    Professor of Medicine
    Chief of Cardiology
    Morehouse School of Medicine
    Medical Director, Heart Failure Program
    Grady Health System
    Atlanta, GA
    Planning Committee
    Gregg Sherman, MD
    National Association for Continuing Education
    Plantation, FL
     
    Harvey C. Parker, Ph.D., CCMEP
    National Association for Continuing Education
    Plantation, FL
     
    Joshua Kilbridge, President
    Kilbridge Associates
    San Francisco, CA
     
    PROGRAM OVERVIEW:
    Heart failure (HF) is a growing problem in the United States, affecting an estimated 5.1 million Americans ≥20 years of age. The disease is a cause for even greater concern among African Americans, in whom the relative incidence is 50% higher compared with the general population. Despite the availability of various treatment options, HF care is suboptimal in clinical practice. Provider barriers include knowledge barriers, diagnostic challenges, pharmacological concerns, communication issues, and personal factors. Early detection of HF can improve outcomes, but the symptoms and signs of HF are often difficult to identify because they are frequently confused with other disorders or are attributed to aging, obesity, or lack of conditioning. As a result, HF is misdiagnosed or underdiagnosed. HF patients may not receive any intervention or may be undertreated, resulting in a very small number of patients reaching goals and recommended levels of therapy with standard treatments including beta blockers, ACE inhibitors, ARBs, and diuretics.
     
    After many years, new treatment options are available with novel mechanisms of action that can improve outcomes when added to optimized, guideline directed medical therapy. This program will raise awareness of risk factors for heart failure and the role of biomarkers, clarify the role that heart rate has in heart failure risk, help participants understand the indications for new therapies and demonstrate how to appropriately incorporate them into clinical practice.
     
    This activity utilizes a flipped classroom design that begins with a foundational self-study followed by an online live webinar, which will be available on-demand after the live event, where all participants will have the opportunity to interact with the faculty and other learners.
     
    DISCLOSURE POLICY STATEMENT:
    It is the policy of ABC and NACE to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. NACE assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter's content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.
     
    While ABC and NACE endeavor to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.
     
    DISCLOSURE OF CONFLICTS OF INTEREST:
     
    Faculty
    Barbara Hutchinson, MD, PhD, FACC has no real or apparent conflicts of interest to report. 
     
    Anekwe Onwuanyi, MD serves as a speaker for Novartis.
     
    Planning Committee
    Gregg Sherman, MD has no real or apparent conflicts of interest to report. 
     
    Harvey Parker, PhD has no real or apparent conflicts of interest to report. 
     
    Joshua Kilbridge has no real or apparent conflicts of interest to report. 
     
    DISCLOSURE OF UNLABELED USE:
    ABC and NACE require that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
     
    DISCLAIMER
    The opinions expressed during the educational activity are those of the faculty and do not necessarily represent the views of ABC and NACE. The information is presented for the purpose of advancing the attendees' professional development.
     
    ACCREDITATION STATEMENT:
    The Association of Black Cardiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. 
     
    This CME activity was planned and produced in accordance with the ACCME Essentials and the AANP CE Standards and Policies and AANP Commercial Support Standards.
     
    For CME questions, please contact: NACE at info@naceonline.com.
     
    Contact this CME provider for privacy and confidentiality policy statement information at: http://www.naceonline.com/privacy_policy.php.
     
    CREDIT DESIGNATION STATEMENT:
    The Association of Black Cardiologists designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim credit commensurate with the extent of their participation in the activity.
     
    The National Association for Continuing Education has approved this program for 1.0 contact hour of continuing education (which includes 0.25 hours of pharmacology).
     
    TO OBTAIN CME CREDITS:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
    • You must score 60% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
    COURSE FORMAT/MEDIUM: Internet CME Activity
     
    ESTIMATED TIME TO COMPLETE: 60 minutes
     
    ACKNOWLEDGEMENT:
    This activity is provided by The Association of Black Cardiologists and The National Association for Continuing Education.   
     
    This activity is supported by educational funding provided by Amgen.
     
    If you have any questions regarding this activity, send an email to info@naceonline.com.
       
    Copyright © 2016 Association of Black Cardiologists and National Association for Continuing Education. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of ABC and NACE is prohibited.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above